The Dark Report Archives

Unilab Pushes Insurers To Increase Cap Rates

CEO SUMMARY: California’s financially destructive capitation rates plunged two more laboratories into bankruptcy. Unilab’s actions indicate that even the largest laboratory company in the state can no longer survive without reimbursement relief. The question remains as to whether managed care plans will agree to pay more for laboratory testing. INDICATIONS ARE THAT CAPITATED RATES for […]

To access this post, you must purchase The Dark Report.

Unilab Pushes Insurers To Increase Cap Rates Read More »

Differing Views About Capitation Rate Trends

Managed Care Contracts / Robert Michel

CEO SUMMARY: Laboratory executives in California believe that capitated rates for laboratory services in the state may soon increase. But no one knows for sure, and no documentation about specific capitation rates for newly signed laboratory services contracts has yet to become public. COMBINING BRAVADO AND BLUFF in one move, Unilab Inc.’s letter-writing blitz to

To access this post, you must purchase The Dark Report.

Differing Views About Capitation Rate Trends Read More »

Plenty Of Money To Go Around

Commentary and Opinion by R. Lewis Dark / R. Lewis Dark

Despite what managed care is doing to clinical laboratories, money abounds to sell more goods. In this issue, you will read about how AmeriPath, Inc. is about to raise $71.7 million while Cytyc Corp. intends to generate $48.2 million in its second public offering in 12 months. The list of laboratory-related companies which raised money

To access this post, you must purchase The Dark Report.

Plenty Of Money To Go Around Read More »

Laboratory Trade Group Launches New Activities

Commentary and Opinion by R. Lewis Dark / Robert Michel

CEO SUMMARY: Long overlooked by most of the laboratory industry, ACLA may be in the process of revolutionary change. Since David Sundwall, M.D., became President, ACLA has taken a more assertive stance on a wide variety of issues which affect all laboratories, not just ACLA members. LONG CONSIDERED by most laboratory executives as a tight

To access this post, you must purchase The Dark Report.

Laboratory Trade Group Launches New Activities Read More »

“January 27, 1997 Intelligence: Late Breaking Lab News”

Late Breaking Lab News / Robert Michel

Persistence can pay off. After years of struggle, Epitope, Inc. of Beaverton, Oregon received a big “shot inthe arm” when the Journal of the American Medical Association (JAMA) reported this month on a clinical study involving Epitope’s OraSure HIV test. The study involved 3,570 patients. It matched results of an HIV blood test against the

To access this post, you must purchase The Dark Report.

“January 27, 1997 Intelligence: Late Breaking Lab News” Read More »

AmeriPath To Go Public, Files SEC Registration

Laboratory Management / Robert Michel

CEO SUMMARY: AmeriPath’s Initial Public Offering will make it the first publicly traded physician practice management company specializing in pathology. It represents a unique attempt to restructure traditional pathology practices to meet the needs of managed healthcare organizations. PATHOLOGY ENTERS A NEW ERA when AmeriPath, Inc. completes its proposed Initial Public Offering (IPO) during the

To access this post, you must purchase The Dark Report.

AmeriPath To Go Public, Files SEC Registration Read More »

Three Public Laboratories Choose New Presidents

Laboratory Management / Robert Michel

CEO SUMMARY: Three public laboratories experiencing serious financial pressure enter the new year with a change in presidents. It is a sign that stockholders and creditors are growing increasingly restless with these organizations’ inability to earn satisfactory profits. Turnover among chief executive officers is usually not a good sign. During the last 45 days, three

To access this post, you must purchase The Dark Report.

Three Public Laboratories Choose New Presidents Read More »

Cytyc Corp. Raising $48 Million To Fund ThinPrep Sales Effort

Laboratory Management / Robert Michel

CEO SUMMARY: Armed with FDA premarket approval, Cytyc must now overcome significant obstacles to introduce its ThinPrep Pap smear system into widespread clinical usage. ANOTHER WELL-FINANCED competitor will soon enter the Pap smear marketplace. Cytyc Corporation is offering 3,000,000 shares to the public with the goal of raising $48.2 million. Cytyc will use $25 million

To access this post, you must purchase The Dark Report.

Cytyc Corp. Raising $48 Million To Fund ThinPrep Sales Effort Read More »

AmeriPath’s Strategies For Business Success

Pathology Trends / Robert Michel

CEO SUMMARY: Two fascinating aspects about the AmeriPath story are: 1) the strategy to boost share values; and 2) the strategy to develop profitable pathology revenues. With managed healthcare transforming pathology at an astounding rate, will AmeriPath succeed in both strategies? DURING THE LAST YEAR, intense curiosity swirled about AmeriPath, Inc. Pathologists heard plenty of

To access this post, you must purchase The Dark Report.

AmeriPath’s Strategies For Business Success Read More »

It Can’t Happen Here

Commentary and Opinion by R. Lewis Dark / R. Lewis Dark

Here is another issue of THE DARK REPORT with stories about radical changes to laboratory organizations. When Canada’s Alberta Province whacked almost 40% out of the healthcare budget over two years, laboratories were left with no option but to engineer radical change. How would laboratories in the United States respond if they were told by

To access this post, you must purchase The Dark Report.

It Can’t Happen Here Read More »